Chromatography analyzer market seen reaching $2 billion by 2030

The healthcare chromatography analyzers market is projected to grow from $1.56 billion in 2025 to $2 billion by 2030, driven by rising chronic disease cases, pharmaceutical research and adoption of higher-automation instruments. North America was the largest regional market in 2025.

Why it matters: - Healthcare chromatography analyzers support clinical diagnostics, pharmaceutical testing and biomarker discovery. - The market’s projected climb to $2 billion by 2030 signals steady demand for tools that improve disease diagnosis, drug monitoring and precision medicine. - Rising chronic disease cases are increasing the need for more accurate analytical systems in healthcare settings.

What happened: - The Business Research Company released a 2026 market report on healthcare chromatography analyzers. - The report says the market will grow from $1.56 billion in 2025 to $1.64 billion in 2026. - The forecast points to $2 billion in market value by 2030. - The report covers regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America was the largest regional market in 2025. - Download a free sample of the report. - View the full report.

The details: - The report places the market at a 5.1% compound annual growth rate from 2025 through 2030. - Growth has been supported by limited availability of advanced chromatography systems, rising clinical diagnostic demand, expanding pharmaceutical research, dependence on manual TLC and LPLC techniques, and stronger demand from life sciences and academic institutions. - Future growth is expected to be driven by UHPLC, LC-MS and GC-MS innovation. - Automation and remote monitoring features are expected to gain traction. - Precision medicine and biomarker analysis are becoming bigger use cases. - The report flags higher adoption of high-resolution chromatography systems. - Automated and portable analyzers are also expected to see broader use. - The report highlights expanded applications in pharmaceuticals and diagnostics. - Consumables are expected to play a larger role in improving accuracy. - Rapid disease detection and biomarker identification are key themes in the forecast. - Healthcare chromatography analyzers separate, identify and quantify components in biological fluids such as blood, urine and tissue extracts. - The instruments are used to support disease diagnosis, drug monitoring and therapeutic research. - In June 2024, the UK National Health Service reported 3,615,330 people registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 cases in 2022.

Between the lines: - The forecast suggests the market is moving from manual methods toward more automated, higher-resolution systems. - Chronic disease growth is likely to keep analytical demand elevated because screening and monitoring require repeat testing. - The emphasis on biomarkers and precision medicine points to a market shift from basic testing toward more targeted clinical applications.

What's next: - The report expects the market to keep expanding at 5.1% annually through 2030. - Report updates include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspot infographics, and updated graphics and tables. - The Business Research Company listed contact details for expert follow-up and report access.